New Migraine Drug Approved By FDA: What You Need To Know

Sleep is one of the most important pillars of our overall health because it gives our body time to rest and recharge, making sure it’s ready to start a new day. However, it’s unfortunate that we have conditions that hinder it, stopping us from getting the break we need, which can negatively affect our health in severe ways over time.

One such condition is migraine, which is characterized by painful headaches that typically lasts anywhere between 4 and 72 hours. They may also occur several times a week to only once a year. And since they’re powerful headaches, they can easily disrupt our sleep cycle, with the irony being that a disrupted sleep cycle can lead to migraines.

Thankfully, people suffering from it who cannot get the relief they want from current medications have a new treatment option since the U.S. Food and Drug Administration recently announced that it has approved of new type of drug for migraine.

Called ubrogepant, the pill is made for the immediate treatment "of  migraine  with or without aura [a sensory phenomenon or visual disturbance] in adults," per the agency. Furthermore, the agency also clarified that it’s not used to prevent migraines but to treat ones in case of an attack.

"Migraine is an often disabling condition that affects an estimated 37 million people in the U.S. Ubrelvy represents an important new option for the acute treatment of migraine in adults, as it is the first drug in its class approved for this indication ,” Dr. Billy Dunn, acting director of the Office of Neuroscience in the FDA's Center for Drug Evaluation and Research, said. 

Per the FDA, the approval came after the results of two studies, which involved more than 1,400 adults, stating that the percentages of patients who achieved freedom from pain after taking the drug are greater than those who didn’t.

With that in mind, the drug also has its share of possible side effects. This includes dry mouth, fatigue and even nausea. According to the FDA, the drug belongs to a new class of medications that has arrived at the market sometime last year.

Migraine Migraines or recurrent headaches can cause severe pain, sensitivity to light and nausea. Hermes Rivera/Unsplash